Restructuring events
European Restructuring Monitor (ERM)
The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
On 2 September 2014, the Danish pharmaceuticals multinational Novo Nordisk announced that it intended to discontinue all its research and development (R&D) activities within its inflammatory disorders division, affecting a total of 400 jobs in Denmark, China and the USA. In the USA, it will close its inflammation research centre in Seattle, with the loss of 63 jobs.
Novo Nordisk currently estimates that it will be possible to offer other positions within the company to more than half of the 400 affected employees. The company has initiated negotiations with the relevant local unions regarding redundancy plans.
Eurofound (2014), Novo Nordisk, Internal restructuring in World, factsheet number 77845, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/77845.